LFVN, US53222K2050

LifeVantage stock adopts a calendar year reporting cycle

Published on 10/07/2026 at 05:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

LifeVantage stock posted USD 42.4 million in Q4 FY2026 revenue, down 23.1 percent year over year. The Nasdaq quote was USD 6.04 on October 6.

LFVN, US53222K2050, Illustration mit AI erstellt.
LFVN, US53222K2050, Illustration mit AI erstellt.

LifeVantage stock (ISIN US53222K2050) was last at USD 6.04 on Nasdaq on October 6, 2026, while the company changes its reporting calendar. According to StockTitan, LifeVantage approved the shift from a June 30 fiscal year end to December 31 on September 29, 2026.

Calendar year changes the reporting frame

The transition period runs from July 1, 2026, through December 31, 2026. The company plans to file an audited Form 10-KT for that six-month period, creating a shorter reporting window before the new calendar-year schedule begins, according to StockTitan.

The change comes as LifeVantage works through a sharp contraction in sales. The Globe and Mail reported that Q4 FY2026 revenue fell 23.1 percent to USD 42.4 million from USD 55.1 million in the prior-year quarter.

Revenue decline pressures profitability

The same Q4 comparison shows gross margin slipping to 78.0 percent from 79.9 percent and GAAP net income declining to USD 1.3 million from USD 2.0 million. Adjusted EBITDA margin fell to 6.5 percent from 8.7 percent, keeping execution under the new leadership team at the center of the investment case.

LifeVantage's full fiscal year 2026 revenue was USD 182.6 million, down 20.1 percent from fiscal 2025, while cash stood at USD 14.9 million and the company carried no debt, according to AInvest. The balance sheet offers flexibility, but the revenue comparison shows why the calendar change is secondary to restoring demand.

Consensus target stays below the quote

MarketBeat reported a consensus Hold rating from two analysts, with an average price target of USD 5.50. Lake Street Capital raised its target from USD 5.00 to USD 6.00 in an August 28, 2026 report, leaving the average target 8.9 percent below the USD 6.04 quote.

LFVN stock remains below its yearly high

On October 6, 2026, LFVN traded between USD 5.99 and USD 6.13 and finished the session's latest quote at USD 6.04, with volume of 30,064 shares. Its 52-week range was USD 3.90 to USD 11.71, placing the quote 48.4 percent below the yearly high and giving the stock a market capitalization of USD 76.2 million.

LifeVantage stock facts

  • Company: LifeVantage Corporation
  • ISIN: US53222K2050
  • Ticker: LFVN
  • Trading venue: Nasdaq
  • Price (as of October 6, 2026, 4:00 p.m. ET): USD 6.04
  • Market capitalization: USD 76.2 million (as of October 6, 2026)
  • 52-week range: USD 3.90-11.71 (as of October 6, 2026)
  • Sector / Industry: Health care / Health and wellness

Upcoming dates for LifeVantage stock

  • November 5, 2026: Annual meeting of stockholders

More news and analyses on LifeVantage stock

Disclaimer...

en | US53222K2050 | LFVN | boerse | 70249789 | bgmi